Table 2.
Multivariate Logistic Regression Analysis for the Association With 1-Year Mortality After Transcatheter Aortic Valve Replacement
| Coefficient | HR (95% CI) | P Value | |
|---|---|---|---|
| Age | 0.02085 | 1.02 (1.01-1.03) | 0.0019 |
| Female | −0.39787 | 0.67 (0.58-0.78) | <0.0001 |
| BMI category | −0.06847 | 0.93 (0.92-0.95) | <0.0001 |
| NYHA functional class III or IV | 0.20989 | 1.23 (1.07-1.43) | 0.0051 |
| CAD | −0.00532 | 1.00 (0.77-1.28) | 0.97 |
| COPD (moderate or severe) | 0.45821 | 1.58 (1.31-1.91) | <0.0001 |
| Hypertension | −0.13896 | 0.87 (0.74-1.02) | 0.084 |
| Insulin-dependent DM | 0.22842 | 1.26 (0.94-1.68) | 0.12 |
| Carotid artery disease | −0.00587 | 0.99 (0.78-1.27) | 0.96 |
| Cerebrovascular disease | 0.15691 | 1.17 (0.96-1.43) | 0.13 |
| Peripheral vessel disease | 0.32908 | 1.39 (1.16-1.66) | 0.0003 |
| Malignancy | 0.50462 | 1.66 (1.38-1.99) | <0.0001 |
| Immunodeficiency | 0.68142 | 1.98 (1.52-2.56) | <0.0001 |
| Previous CABG | 0.22975 | 1.26 (0.94-1.69) | 0.13 |
| Previous PCI | −0.10409 | 0.90 (0.70-1.17) | 0.43 |
| Pulmonary hypertension | 0.04107 | 1.04 (0.88-1.23) | 0.63 |
| Porcelain aorta | 0.3249 | 1.38 (1.14-1.69) | 0.0013 |
| Hemoglobin | −0.1201 | 0.89 (0.85-0.93) | <0.0001 |
| Albumin | −0.46427 | 0.63 (0.56-0.71) | <0.0001 |
| Creatinine | 0.05308 | 1.06 (1.03-1.08) | 0.0002 |
| Aortic insufficiency grade III or IV at baseline | −0.18312 | 0.83 (0.66-1.06) | 0.13 |
| Mitral insufficiency grade III or IV at baseline | 0.02473 | 1.03 (0.82-1.29) | 0.83 |
| Bicuspid aortic valve | −0.11631 | 0.89 (0.56-1.41) | 0.62 |
| LVEF per 1% increment | 0.00217 | 1.00 (1.00-1.01) | 0.44 |
| Aortic valve mean gradient at baseline per 1 mm Hg increment | −0.01447 | 0.99 (0.98-0.99) | <0.0001 |
| Aortic valve area at baseline per 1 cm2 increment | −0.15607 | 0.86 (0.65-1.12) | 0.25 |
| Nonelective procedure | 0.57834 | 1.78 (1.27-2.50) | 0.0008 |
Abbreviations as in Table 1.